Spire Healthcare Group (LON:SPI) Sets New 52-Week Low – Here’s Why

Shares of Spire Healthcare Group plc (LON:SPI) reached a new 52-week low during trading on Thursday . The company traded as low as GBX 214.86 ($2.79) and last traded at GBX 215.50 ($2.79), with a volume of 294021 shares traded. The stock had previously closed at GBX 220.50 ($2.86).

Analysts Set New Price Targets

Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 300 ($3.89) price objective on shares of Spire Healthcare Group in a research note on Tuesday, September 17th.

Spire Healthcare Group Stock Performance

The company has a market cap of £870.23 million, a PE ratio of 3,150.00, a PEG ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 169.51, a quick ratio of 0.74 and a current ratio of 0.70. The firm’s 50 day moving average is GBX 237.10 and its 200-day moving average is GBX 243.66.

Insider Buying and Selling at Spire Healthcare Group

In other news, insider Justin Ash bought 21,100 shares of the firm’s stock in a transaction on Tuesday, September 17th. The shares were bought at an average cost of GBX 236 ($3.06) per share, for a total transaction of £49,796 ($64,577.88). 34.71% of the stock is currently owned by company insiders.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.